Artivion, Inc., a prominent player in the cardiac and vascular surgery sector, has announced the release date for its third quarter 2025 financial results. The company will unveil its earnings on November 6, 2025, after the market closes. This disclosure is a key moment for investors and stakeholders interested in the company’s performance in addressing aortic disease.
On the same day, Artivion will conduct a teleconference call and live webcast at 4:30 p.m. ET to discuss the financial outcomes. The session will be led by Pat Mackin, the Chairman, President, and Chief Executive Officer of Artivion. Participants can join the call by dialing 201-689-8261 shortly before the event begins. A replay of the teleconference will be available approximately one hour after its conclusion. Interested parties can access the replay by calling 877-660-6853 or 201-612-7415, using the conference number 13755945.
For those preferring online access, the live webcast and its replay will be available on the Investors section of the Artivion website. The webcast can be found by selecting the “Webcasts & Presentations” option. Additionally, a detailed earnings press release containing financial and statistical information for the quarter and the full year will also be posted on the company’s website.
About Artivion
Based in suburban Atlanta, Georgia, Artivion, Inc. specializes in developing innovative solutions for cardiac and vascular surgeons tackling complex challenges in the treatment of aortic diseases. The company’s diverse product range includes aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion’s products are available in over 100 countries globally, reflecting its commitment to enhancing surgical outcomes and patient care.
For more information about Artivion and its offerings, visit the official website at www.artivion.com.
For inquiries, you may contact:
Lance A. Berry
Executive Vice President, Chief Operating Officer & Chief Financial Officer
Phone: 770-419-3355
Gilmartin Group LLC**
Brian Johnston
Laine Morgan
Phone: 332-895-3222
Email: [email protected]
This upcoming financial disclosure is a significant event for Artivion, providing insights into the company’s performance and strategies in the evolving medical device market.
